City

Liaocheng (1)

Minneapolis (1)

Surat (1)

Condition

Lymphoma Leukemia (3)

Overall Status

Completed (1)

Not yet recruiting (1)

Unknown status (1)

Sign in for free

Phase

early phase 1 (1)

n/a (1)

phase 1/phase 2 (1)

Sponsor

Masonic Cancer Center, University of Minnesota (1)

Sutphin Drugs (1)

UWELL Biopharma (1)

Collaborator

Bharath Charitable Cancer Hospital and Institute (1)

Liaocheng People's Hospital (1)

Intervention

allogeneic car19 regulatory t cells (car19-ttreg) (1)

cyclophosphamide (1)

doxorubicin (1)

fludarabine (1)

welgenaleucel (1)

Study Documents

Intervention Type

drug (2)

genetic (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

lymphoma leukemia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Lymphoma Leukemia Trial in Minneapolis (allogeneic CAR19 regulatory T cells (CAR19-tTreg))

Not yet recruiting

Lymphoma Leukemia

allogeneic CAR19 regulatory T cells (CAR19-tTreg)
+2 more

Minneapolis, Minnesota

Masonic Cancer Center - University of Minnesota

Dec 6, 2022

Lymphoma Leukemia Trial in Surat (Doxorubicin)

Unknown status

Lymphoma Leukemia

Doxorubicin

Surat, Gujarat, India

Bharat Cancer Hospital

Jun 3, 2019

Lymphoma Leukemia Trial in Liaocheng (Welgenaleucel)

Completed

Lymphoma Leukemia

Welgenaleucel

Liaocheng, Shandong, China

Liaocheng People Hospital

Jan 17, 2019